Delving into the Latest Updates on Beijing Estone Science and Technology Development Co., Ltd. with Synapse

Overview

Tags

Urogenital Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Immune System Diseases	1

Top 5 Drug Type	Count

Herbal medicine	1

1.初步评价益肾化浊颗粒延缓慢性肾功能衰竭进展的作用。 2.初步评价益肾化浊颗粒与缬沙坦胶囊合用对慢性肾功能衰竭的证候改善作用。 3.探索益肾化浊颗粒治疗慢性肾功能衰竭的合理剂量。 4.观察益肾化浊颗粒的安全性及不良反应。

[Translation]

1. To preliminarily evaluate the effect of Yishen Huazhuo Granules in delaying the progression of chronic renal failure. 2. To preliminarily evaluate the effect of Yishen Huazhuo Granules combined with valsartan capsules on improving the symptoms of chronic renal failure. 3. To explore the reasonable dose of Yishen Huazhuo Granules in the treatment of chronic renal failure. 4. To observe the safety and adverse reactions of Yishen Huazhuo Granules.

Start Date-

Sponsor / Collaborator

Beijing Estone Science and Technology Development Co., Ltd.

100 Clinical Results associated with Beijing Estone Science and Technology Development Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Beijing Estone Science and Technology Development Co., Ltd.

Login to view more data

100 Deals associated with Beijing Estone Science and Technology Development Co., Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Estone Science and Technology Development Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2

1

Login to view more data